Archives
-
CFDA SE Cell Tracer Kit: Practical Guide
2026-08-15
The CFDA SE Cell Tracer Kit provides stable fluorescent labeling for cell proliferation studies, cell lineage tracing, and longer-term population tracking in vitro or in vivo. It is intended for persistent covalent tagging, not reversible labeling, rapid dye-clearance experiments, or workflows that require short-lived fluorescence.
-
Aurora A Overexpression in High-Risk Retinoblastoma
2026-08-14
A 2024 study identifies Aurora kinase A (AURKA) overexpression as a frequent feature of advanced human retinoblastoma and links it to histopathologic factors associated with poor outcome. By combining patient-tissue analysis with depletion, pharmacologic inhibition, patient-derived models, and xenografts, the work supports AURKA as a functionally relevant target while leaving ocular drug delivery and clinical efficacy for future investigation.
-
Tigecycline: Glycylcycline Antibiotic Research
2026-08-14
Tigecycline is a glycylcycline antibiotic and bacteriostatic 30S ribosomal subunit inhibitor with activity against selected resistant Gram-positive and Gram-negative bacteria. Its validated research uses include MRSA studies, GISA infection models, and controlled investigations of complicated skin and skin-structure infections, while its clinical limitations require careful interpretation of in-vitro susceptibility data.
-
Tigecycline Assays for Plasmid-Borne CREC
2026-08-13
Tigecycline offers a glycylcycline antibiotic framework for studying difficult bacterial phenotypes, but carbapenemase gene mobility demands more careful assay design. This article translates CREC transmission findings into practical, genotype-aware research workflows.
-
Kupffer Cell Plasticity in Liver Metastasis
2026-08-13
The reference study shows that liver metastasis-associated macrophages are maintained not only by recruited monocytes but also by local macrophage proliferation and infiltration of plastic Kupffer cells. Its lineage-tracing, proliferation-recording, flow-cytometry, imaging, and CITE-seq approaches reveal why blocking monocyte-derived macrophages alone may provide limited control of the immunosuppressive metastatic niche.
-
ML133 HCl: A Better Kir2.1 Assay Strategy
2026-08-12
ML133 HCl is a selective potassium channel inhibitor for dissecting Kir2.1 biology in pulmonary vascular models. This guide develops a pH-aware, causality-focused assay strategy grounded in PASMC proliferation and migration research.
-
Angiotensin 1/2 (2-7) Peptide: RAS Research Guide
2026-08-12
Angiotensin 1/2 (2-7) is a six-residue angiotensin peptide fragment used in renin-angiotensin signaling pathway and blood pressure regulation research. Product specifications report 99.80% purity, a molecular weight of 783.92 g/mol, and high stated solubility in water and DMSO, while recent binding data position the fragment in exploratory SARS-CoV-2 spike–AXL studies.
-
1-Myristoylglycerophosphocholine: Assay Strategy
2026-08-11
1-myristoylglycerophosphocholine, also called 14:0 Lyso-PC, can help researchers separate defined lipid-species effects from broader lysophosphatidylcholine responses. This article develops a source-to-function assay strategy grounded in pulmonary fibrosis research and practical smooth muscle experimentation.
-
Meropenem trihydrate: Reliable Cell Assays
2026-08-11
A scenario-driven guide to using Meropenem trihydrate (SKU B1217) in cell viability, infection, and antibiotic resistance workflows. It connects formulation data with practical controls, stock preparation, resistance interpretation, and vendor-selection decisions.
-
HNF4A-AS1 Reprograms Lipid Metabolism in HCC
2026-08-10
A 2024 Theranostics study identifies the liver-enriched lncRNA HNF4A-AS1 as a regulator of sorafenib sensitivity in hepatocellular carcinoma. Its mechanistic data connect HNF4A-AS1 to METTL3-dependent m6A modification of DECR1 mRNA, PUFA availability, and ferroptosis, providing a framework for studying metabolic resistance rather than treating sorafenib failure as a single signaling defect.
-
2-NBDG for Mechanistic Glucose Uptake Studies
2026-08-09
2-NBDG enables single-cell and population-level analysis of glucose uptake. This guide connects assay design with new evidence on neuronal glycogen metabolism, helping researchers distinguish glucose entry from downstream metabolic flux.
-
Partial BACE Inhibition and Synaptic Transmission
2026-08-08
Satir et al. examined whether moderate β-secretase inhibition can lower amyloid-β (Aβ) secretion without disrupting neuronal communication. Using primary rat cortical neurons, optical electrophysiology, and three BACE inhibitors—including lanabecestat (AZD3293)—the study found a synaptic-sparing window when Aβ production was reduced by less than 50%, whereas stronger inhibition decreased synaptic transmission.
-
Auranofin at the Redox–Metabolism Interface
2026-08-07
A translational perspective on how Auranofin-driven thioredoxin reductase inhibition can be evaluated alongside tumor metabolism, radiation response, and apoptosis biology—while separating validated evidence from hypothesis-generating strategy.
-
Sulfaphenazole Restores Perfusion in Ischemic Skin Injury Mo
2026-08-07
A recent study demonstrates that sulfaphenazole, a selective CYP2C9 inhibitor, markedly reduces the severity of thermal and pressure-induced skin injuries by rapidly restoring tissue blood flow and limiting inflammatory damage. These findings provide mechanistic insight into the role of cytochrome P450 2C9 inhibition in mitigating ischemia–reperfusion injury and highlight sulfaphenazole’s translational potential in vascular and tissue repair research.
-
IPR-803: Mechanistic Insights and Translational Impact in Tu
2026-08-06
Explore how IPR-803, a potent urokinase receptor inhibitor, enables precise targeting of the uPAR–uPA axis in cancer metastasis models. This article offers advanced mechanistic analysis and practical guidance for researchers seeking to leverage IPR-803 in translational oncology.
555 records 8/37 page Previous Next First page 上5页 678910 下5页 Last page